Cm. Storgard et al., Decreased angiogenesis and arthritic disease in rabbits treated with an alpha v beta 3 antagonist, J CLIN INV, 103(1), 1999, pp. 47-54
Rheumatoid arthritis (RA) is an inflammatory disease associated with intens
e angiogenesis and vascular expression of integrin alpha v beta 3. Intra-ar
ticular administration of a cyclic peptide antagonist of integrin alpha v b
eta 3 to rabbits with antigen-induced arthritis early in disease resulted i
n inhibition of synovial angiogenesis and reduced synovial cell infiltrate,
pannus formation, and cartilage erosions. These effects were not associate
d with lymphopenia or impairment of leukocyte function. Furthermore, when a
dministered in chronic, preexisting disease, the alpha v beta 3 antagonist
effectively diminished arthritis severity and was associated with a quantit
ative increase in apoptosis of the angiogenic blood vessels. Therefore, ang
iogenesis appears to be a central factor in the initiation and persistence
of arthritic disease, and antagonists of integrin alpha v beta 3 may repres
ent a novel therapeutic strategy for RA.